Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.37 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.36 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.36 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.36 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 3/20 | 0.34 |
| ▸ | LMNA | P02545 | 2/20 | 0.34 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.34 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | GALR3 | O60755 | 1/20 | 0.34 |
| ▸ | BLM | P54132 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | PRKCA | P17252 | 2/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28638213 | 0.89 | — | — | |
| SCHEMBL7363048 | 0.83 | TSHR (0.30) | TSHRCHRM2CHRM4CHRM1TBXA2R | |
| SCHEMBL15446662 | 0.81 | TSHR (0.42) | TSHRTDP1LMNACYP2C9SMN1; SMN2 | |
| SCHEMBL36038 | 0.80 | — | — | |
| SCHEMBL2153425 | 0.80 | — | — | |
| SCHEMBL320015 | 0.80 | — | — | |
| SCHEMBL2153285 | 0.80 | — | — | |
| SCHEMBL12262559 | 0.79 | MAPT (0.39) | TSHRTDP1MAPTLMNAPRKCA | |
| SCHEMBL4812705 | 0.78 | TSHR (0.33) | TSHRCHRM2CHRM4CHRM1TBXA2R | |
| Water SCHEMBL251200 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7488835-B2 | Process for the preparation of alkylene carbonates | SHELL OIL COMPANY (US) | 2009-02-10 | — | — | US | disclosed |
| EP-1910327-B1 | PROCESS FOR THE PREPARATION OF ALKYLENE CARBONATES | SHELL INT RESEARCH (NL) | 2009-01-14 | — | — | EP | disclosed |
| EP-1910327-A1 | PROCESS FOR THE PREPARATION OF ALKYLENE CARBONATES | Shell Internationale Research Maatschappij B.V. (NL) | 2008-04-16 | — | — | EP | disclosed |
| US-20070179303-A1 | PROCESS FOR THE PREPARATION OF ALKYLENE CARBONATES | SHELL OIL COMPANY | 2007-08-02 | — | — | US | disclosed |
| WO-2007014958-A1 | PROCESS FOR THE PREPARATION OF ALKYLENE CARBONATES | SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V. (NL) | 2007-02-08 | — | — | WO | disclosed |
| EP-0839811-B1 | Method for catalytic conversion of carbon dioxide | ISKRA INDUSTRY CO LTD (JP) | 2002-06-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070179303-A1 | PROCESS FOR THE PREPARATION OF ALKYLENE CARBONATES | CA12, CYCS, CTRC | TSHR 3106/4885CHRM2 1132/4885CHRM4 697/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.